NDC 85534-0013-01 - Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85534-0013
- Requested NDC
- 85534-0013-01
- Package NDCs from labels
- 85534-0013-0, 85534-0013-1, 85534-0013-2, 85534-0013-3, 85534-0013-01
- Manufacturer
- HAWAII REPACK, INC.
- Effective date
- 2026-06-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ibuprofen Tablets, USP Rx only | HAWAII REPACK, INC. | 2026-06-26 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Equate ClearLAX | POLYETHYLENE GLYCOL 3350 | WALMART INC. | c5c13378-3c08-415f-8ab4-8a18d6300ca8 | 2022-09-08 | Warnings | G2M7P15E5P |
| Ibuprofen | IBUPROFEN | Aurohealth LLC | e1b49257-d226-457f-8f2d-9a757a65bbcb | 2022-09-06 | Warnings | WK2XYI10QM |
| Hendel Periodontal and Tooth Pain Relief | SODIUM BORATE, TRIBASIC CALCIUM PHOSPHATE, MERCURIUS SOLUBILIS, AND SILICON DIOXIDE | MediNatura Inc | f34e9f77-69fd-4c7f-9eea-2d721a4d27fb | 2022-08-22 | Warnings | ETJ7Z6XBU4 |
| Diphenhydramine HCl and Ibuprofen | DIPHENHYDRAMINE HCL AND IBUPROFEN | Aurohealth LLC | 2c7c5349-06c9-401a-88e9-8f91ddb7f91a | 2022-08-19 | Warnings | WK2XYI10QM |
| injoy constipation relief | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | b2414517-04bf-4f29-951e-b867855078c3 | 2022-08-19 | Warnings | G2M7P15E5P |
| Ibuprofen Oral | IBUPROFEN ORAL | Strategic Sourcing Services | a3062142-db0e-4758-a762-2b2bb05670b1 | 2022-08-10 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN TABLET, FILM-COATED | Lil' Drug Store Products, Inc. | e5bf5e09-7d42-6314-e053-2a95a90a2325 | 2022-08-08 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | DOLGENCORP, INC. | df321783-73cb-55bf-e053-2a95a90a4ce2 | 2022-07-07 | Warnings | WK2XYI10QM |
| Good Sense Clear Lax | POLYETHYLENE GLYCOL 3350 | Proficient Rx LP | 0858a914-4812-4e4d-82f8-ecf93d43ef3b | 2022-07-01 | Warnings | G2M7P15E5P |
| Ibuprofen | IBUPROFEN | Proficient Rx LP | b7565aac-a928-4116-b9af-cf636da4537c | 2022-07-01 | Warnings | WK2XYI10QM |
| Ibuprofen and Diphenhydramine Citrate | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | Aurohealth LLC | 21c1f5c5-19fa-4a59-bad3-ea85fd37471b | 2022-06-03 | Warnings | WK2XYI10QM |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Proficient Rx LP | 199d6173-3fad-49e4-88fe-bde7223ed4c3 | 2022-06-01 | Warnings | G2M7P15E5P |
| Ibuprofen | IBUPROFEN | CARDINAL HEALTH | dfbbde4f-633d-6d57-e053-2a95a90ad82f | 2022-05-24 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Aurohealth LLC | 7779c369-50bf-4cde-9015-ff3fb35e128e | 2022-05-16 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Proficient Rx LP | d2c7f045-e70c-4e2b-b2e0-d81a271d0a04 | 2022-05-01 | Boxed warning, Warnings, Adverse reactions | 197806 WK2XYI10QM |
| Motrin IB | IBUPROFEN | Jones Healthcare Group - Packaging Services, Inc | 6419cc78-27d4-7713-e053-2a91aa0a5a10 | 2022-04-29 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Proficient Rx LP | 2dc3108f-d917-40c6-865d-c900cf055d1c | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 197807 WK2XYI10QM |
| ibuprofen | IBUPROFEN | Proficient Rx LP | 798d33b0-5d7a-4445-8a51-2a3d336f744a | 2022-04-01 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Proficient Rx LP | 444b2ea0-ec42-4bcf-b8d2-38b4b297ada0 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | 197805 WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Aurohealth LLC | 1100648c-6b9f-49c9-94d0-c40f24fe5c27 | 2022-03-23 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.